GlobeNewswire·May 28, 2026, 7:00 AM ET

Sono-Tek Reports Fiscal Fourth Quarter and Full Year 2026 Financial Results

SOTK

Sono-Tek Corporation reported fiscal year 2026 net sales of $20.9 million, representing a 2% increase year-over-year & marking the second consecutive year with revenue exceeding $20 million.
The company achieved an eighth consecutive quarter with revenue above $5 million, recording Q4 FY 2026 sales of $5.6 million, a 10% increase from the prior year.
Gross margin expanded to 51% for FY 2026 from 47.5% in FY 2025, driven by a favorable product mix of high-ASP systems & increased U.S. market sales.
Operating income surged 81% to $1.82 million, while net income grew 42% to approximately $1.8 million for the full fiscal year 2026.
Medical sector sales increased 54% year-over-year, fueled by demand for balloon catheter coating systems, stent applications, & diagnostic devices.
Electronics market sales rose 16%, supported by growth in electrically active coatings for diagnostic applications.
Alternative/clean energy sector sales declined 19% due to reduced demand for electrolysis systems resulting from government policy changes & incentive eliminations.
In-Line Coating Systems revenue increased 91%, driven by shipments of eight high-ASP systems to a solar customer.
Backlog remained strong at $9.12 million at fiscal year-end, an increase of 5% from the previous year.
The company ended FY 2026 with $14.8 million in cash, cash equivalents, & marketable securities, with no outstanding debt.
Sono-Tek anticipates continued revenue growth & profitability in the first half of FY 2027, driven by the medical sector & high-ASP system adoption.
Full-year FY 2027 revenue is projected to be relatively flat to modestly higher, with uncertainty persisting in certain clean energy sectors.
A conference call to discuss these results is scheduled for 10:30 AM ET on May 28, 2026.